Natriuretic Peptides and the Management of Heart Failure
Tyler Kern, MD, Ilan Kedan, MD, MPH, Asher Kimchi, MD
Natriuretic peptide has been validated as a useful biomarker in the diagnosis of heart failure, although its role in guiding medical management of heart failure is not well established. The authors investigated if natriuretic peptide–guided therapy was associated with improved outcomes for heart failure patients.
Management of Patients With Stable Angina and Type 2 Diabetes
Prakash C. Deedwania, MD, FACC, FAHA
This review discusses the effectiveness of common antianginal and anti-ischemic therapies and the potential implications of their effect on glucose control for treatment of patients with stable angina and comorbid type 2 diabetes.
Renal Denervation: Past, Present, and Future
Bashar Hannawi, MD, Homam Ibrahim, MD, Colin M. Barker, MD
This article reviews the available literature and proposes future directions for renal denervation studies. It also provides a detailed comparison of the available catheters and their respective clinical data.
Implementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes: Vytorin Efficacy International Trial
Boback Ziaeian, MD, John Dinkler, MD, MPH, Karol Watson, MD, PhD
Primary care physicians and cardiologists play key roles in identifying populations at elevated atherosclerotic cardiovascular disease risk. In providing a practical management overview of the current blood cholesterol guideline, the authors facilitate more informed discussions on treatment options between healthcare providers and their patients.
Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome
Davide Capodanno, MD, PhD, Giuseppe Gargiulo, MD, Giovanni Longo, MD, Corrado Tamburino, MD, PhD
Bifurcation geometry and plaque distribution in a diseased left main artery (LM) have the potential to drive operators’ decisions regarding treatment strategies, techniques, and material selection. The three-dimensional (3D) geometry of the LM bifurcation typically results in specific patterns of plaque distribution. Plaque distribution may, in turn, significantly affect the procedural and long-term clinical and angiographic outcomes of LM percutaneous coronary intervention. Each LM bifurcation must be treated according to its unique anatomic and pathologic characteristics. Novel classification schemes of plaque distribution and 3D assessment may be valuable aids to get a working picture of the bifurcation geometry.
Novel Agents for the Prevention and Management of Hyperkalemia
Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP, FNKF, FNLA, Maria Rosa Costanzo, MD, Marc Silver, MD, Bruce Spinowitz, MD, Jun Zhang, MD, MS, Norman E. Lepor, MD, FACC, FAHA, FSCA
This review highlights the major mechanisms of hyperkalemia and key results from randomized trials in a range of clinical scenarios in patients with, and at risk for, hyperkalemia.
Home Telemedicine in Heart Failure: A Pilot Study of Integrated Telemonitoring and Virtual Provider Appointments
Shadi Idris, MD, George Degheim, MD, Wael Ghalayini, MD, Timothy R. Larsen, DO, Davar Nejad, MD, Shukri David, MD
Update From the California Chapter of The American College of Cardiology
Norman E. Lepor, MD, FACC, FAHA, FSCAI
Silk Suture Embolization for Sealing Distal Coronary Artery Perforation: Report of Two Cases
Yue Li, MD, Guotao Wang, MD, Li Sheng, MD, Jingyi Xue, MD, Danghui Sun, MM, Yongtai Gong, MD
Coronary artery perforation (CAP) is an infrequent yet potentially life-threatening complication of percutaneous coronary intervention. The authors report for the first time two cases of successful closure of guidewire-induced distal CAP with silk suture embolization using a microcatheter.
Now available for your iPhone and iPad
Natriuretic Peptides and the Management of Heart Failure
Tyler Kern, MD, Ilan Kedan, MD, MPH, Asher Kimchi, MD
Natriuretic peptide has been validated as a useful biomarker in the diagnosis of heart failure, although its role in guiding medical management of heart failure is not well established. The authors investigated if natriuretic peptide–guided therapy was associated with improved outcomes for heart failure patients.
Management of Patients With Stable Angina and Type 2 Diabetes
Prakash C. Deedwania, MD, FACC, FAHA
This review discusses the effectiveness of common antianginal and anti-ischemic therapies and the potential implications of their effect on glucose control for treatment of patients with stable angina and comorbid type 2 diabetes.
Renal Denervation: Past, Present, and Future
Bashar Hannawi, MD, Homam Ibrahim, MD, Colin M. Barker, MD
This article reviews the available literature and proposes future directions for renal denervation studies. It also provides a detailed comparison of the available catheters and their respective clinical data.
Implementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes: Vytorin Efficacy International Trial
Boback Ziaeian, MD, John Dinkler, MD, MPH, Karol Watson, MD, PhD
Primary care physicians and cardiologists play key roles in identifying populations at elevated atherosclerotic cardiovascular disease risk. In providing a practical management overview of the current blood cholesterol guideline, the authors facilitate more informed discussions on treatment options between healthcare providers and their patients.
Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome
Davide Capodanno, MD, PhD, Giuseppe Gargiulo, MD, Giovanni Longo, MD, Corrado Tamburino, MD, PhD
Bifurcation geometry and plaque distribution in a diseased left main artery (LM) have the potential to drive operators’ decisions regarding treatment strategies, techniques, and material selection. The three-dimensional (3D) geometry of the LM bifurcation typically results in specific patterns of plaque distribution. Plaque distribution may, in turn, significantly affect the procedural and long-term clinical and angiographic outcomes of LM percutaneous coronary intervention. Each LM bifurcation must be treated according to its unique anatomic and pathologic characteristics. Novel classification schemes of plaque distribution and 3D assessment may be valuable aids to get a working picture of the bifurcation geometry.
Novel Agents for the Prevention and Management of Hyperkalemia
Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP, FNKF, FNLA, Maria Rosa Costanzo, MD, Marc Silver, MD, Bruce Spinowitz, MD, Jun Zhang, MD, MS, Norman E. Lepor, MD, FACC, FAHA, FSCA
This review highlights the major mechanisms of hyperkalemia and key results from randomized trials in a range of clinical scenarios in patients with, and at risk for, hyperkalemia.
Home Telemedicine in Heart Failure: A Pilot Study of Integrated Telemonitoring and Virtual Provider Appointments
Shadi Idris, MD, George Degheim, MD, Wael Ghalayini, MD, Timothy R. Larsen, DO, Davar Nejad, MD, Shukri David, MD
Update From the California Chapter of The American College of Cardiology
Norman E. Lepor, MD, FACC, FAHA, FSCAI
Silk Suture Embolization for Sealing Distal Coronary Artery Perforation: Report of Two Cases
Yue Li, MD, Guotao Wang, MD, Li Sheng, MD, Jingyi Xue, MD, Danghui Sun, MM, Yongtai Gong, MD
Coronary artery perforation (CAP) is an infrequent yet potentially life-threatening complication of percutaneous coronary intervention. The authors report for the first time two cases of successful closure of guidewire-induced distal CAP with silk suture embolization using a microcatheter.
Now available for your iPhone and iPad
Natriuretic Peptides and the Management of Heart Failure
Tyler Kern, MD, Ilan Kedan, MD, MPH, Asher Kimchi, MD
Natriuretic peptide has been validated as a useful biomarker in the diagnosis of heart failure, although its role in guiding medical management of heart failure is not well established. The authors investigated if natriuretic peptide–guided therapy was associated with improved outcomes for heart failure patients.
Management of Patients With Stable Angina and Type 2 Diabetes
Prakash C. Deedwania, MD, FACC, FAHA
This review discusses the effectiveness of common antianginal and anti-ischemic therapies and the potential implications of their effect on glucose control for treatment of patients with stable angina and comorbid type 2 diabetes.
Renal Denervation: Past, Present, and Future
Bashar Hannawi, MD, Homam Ibrahim, MD, Colin M. Barker, MD
This article reviews the available literature and proposes future directions for renal denervation studies. It also provides a detailed comparison of the available catheters and their respective clinical data.
Implementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes: Vytorin Efficacy International Trial
Boback Ziaeian, MD, John Dinkler, MD, MPH, Karol Watson, MD, PhD
Primary care physicians and cardiologists play key roles in identifying populations at elevated atherosclerotic cardiovascular disease risk. In providing a practical management overview of the current blood cholesterol guideline, the authors facilitate more informed discussions on treatment options between healthcare providers and their patients.
Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome
Davide Capodanno, MD, PhD, Giuseppe Gargiulo, MD, Giovanni Longo, MD, Corrado Tamburino, MD, PhD
Bifurcation geometry and plaque distribution in a diseased left main artery (LM) have the potential to drive operators’ decisions regarding treatment strategies, techniques, and material selection. The three-dimensional (3D) geometry of the LM bifurcation typically results in specific patterns of plaque distribution. Plaque distribution may, in turn, significantly affect the procedural and long-term clinical and angiographic outcomes of LM percutaneous coronary intervention. Each LM bifurcation must be treated according to its unique anatomic and pathologic characteristics. Novel classification schemes of plaque distribution and 3D assessment may be valuable aids to get a working picture of the bifurcation geometry.
Novel Agents for the Prevention and Management of Hyperkalemia
Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP, FNKF, FNLA, Maria Rosa Costanzo, MD, Marc Silver, MD, Bruce Spinowitz, MD, Jun Zhang, MD, MS, Norman E. Lepor, MD, FACC, FAHA, FSCA
This review highlights the major mechanisms of hyperkalemia and key results from randomized trials in a range of clinical scenarios in patients with, and at risk for, hyperkalemia.
Home Telemedicine in Heart Failure: A Pilot Study of Integrated Telemonitoring and Virtual Provider Appointments
Shadi Idris, MD, George Degheim, MD, Wael Ghalayini, MD, Timothy R. Larsen, DO, Davar Nejad, MD, Shukri David, MD
Update From the California Chapter of The American College of Cardiology
Norman E. Lepor, MD, FACC, FAHA, FSCAI
Silk Suture Embolization for Sealing Distal Coronary Artery Perforation: Report of Two Cases
Yue Li, MD, Guotao Wang, MD, Li Sheng, MD, Jingyi Xue, MD, Danghui Sun, MM, Yongtai Gong, MD
Coronary artery perforation (CAP) is an infrequent yet potentially life-threatening complication of percutaneous coronary intervention. The authors report for the first time two cases of successful closure of guidewire-induced distal CAP with silk suture embolization using a microcatheter.
Now available for your iPhone and iPad